| Title |
Pharmacogenomics Knowledge for Personalized Medicine
|
|---|---|
| Published in |
Clinical Pharmacology & Therapeutics, September 2012
|
| DOI | 10.1038/clpt.2012.96 |
| Pubmed ID | |
| Authors |
M Whirl‐Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein |
| Abstract |
The Pharmacogenomics Knowledgebase (PharmGKB) is a resource that collects, curates, and disseminates information about the impact of human genetic variation on drug responses. It provides clinically relevant information, including dosing guidelines, annotated drug labels, and potentially actionable gene-drug associations and genotype-phenotype relationships. Curators assign levels of evidence to variant-drug associations using well-defined criteria based on careful literature review. Thus, PharmGKB is a useful source of high-quality information supporting personalized medicine-implementation projects. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 75% |
| United Kingdom | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Scientists | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,402 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | <1% |
| Canada | 3 | <1% |
| Brazil | 3 | <1% |
| France | 2 | <1% |
| Italy | 2 | <1% |
| United Kingdom | 2 | <1% |
| Australia | 1 | <1% |
| India | 1 | <1% |
| Czechia | 1 | <1% |
| Other | 9 | <1% |
| Unknown | 1366 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 254 | 18% |
| Student > Ph. D. Student | 202 | 14% |
| Student > Master | 192 | 14% |
| Researcher | 188 | 13% |
| Other | 72 | 5% |
| Other | 233 | 17% |
| Unknown | 261 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 298 | 21% |
| Agricultural and Biological Sciences | 207 | 15% |
| Medicine and Dentistry | 202 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 146 | 10% |
| Computer Science | 60 | 4% |
| Other | 178 | 13% |
| Unknown | 311 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2022.
All research outputs
#1,761,456
of 25,837,817 outputs
Outputs from Clinical Pharmacology & Therapeutics
#253
of 4,619 outputs
Outputs of similar age
#11,153
of 193,567 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#2
of 47 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,619 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,567 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.